Showing posts with label PDLI. Show all posts
Showing posts with label PDLI. Show all posts

Monday, March 4, 2013

Barchart Morning Call 3/4



OVERNIGHT MARKETS AND NEWS
March E-mini S&Ps (ESH13 -0.10%) are down -0.35% on sell-offs in European (-0.33%) and Asian stocks and on the weak Chinese non-manufacturing PMI reported on Saturday. In addition, political comments over the weekend seemed to confirm that there is little change of rolling back the sequester cuts that began last Friday. Most Asian stock markets are trading lower today except for a +0.40% rally in Japan. Commodity prices are little changed on average this morning. April crude oil (CLJ13 +0.09%) is down -0.18%, April gasoline (RBJ13 +0.01%) is down -0.28%, April gold (GCJ13 +0.36%) is up +0.36%, May copper (HGK13 +0.54%) is down -0.07%, and agricultural prices are mixed. The dollar index (DXY00 +0.04%) is slightly higher by +0.07%. EUR/USD (^EURUSD) is down -0.16% and USD/JPY (^USDJPY) is down -0.09%. June 10-year T-notes (ZNM13 +0.01%) are up 3.5 ticks.
HSBC is down 2.5% in European trading after reporting that its profit fell 5.6% in 2012 after taking a $5.2 billion charge. HSBC was forced to revalue its impaired debt, pay a record penalty for compliance violations, and saw higher costs.
Chinese stocks fell sharply by 4.6% today in response to a new set of property market curbs to cool home prices that hit construction and developer stocks hard. The Chinese government cabinet late Friday announced measures such as higher down payments and mortgage rates on second homes in cities that have experienced steep home price increases. The cabinet also announced a 20% capital gains tax on existing home sales.
Chinese stocks were also hurt by Saturday's news that China's Feb non-manufacturing PMI from the National Bureau of Statistics fell by 1.7 points to 54.5 from 56.2 in Jan.
Japanese stocks were supported today and closed up +0.40% after Haruhiko Kuroda, who has been nominated as the new Bank of Japan chief, said he would do whatever it takes to end more than 15 years of deflation.
Japan's Feb monetary base surged to +15.0% y/y from +10.9% y/y in Jan.
The UK Feb construction PMI fell by -1.9 points to 46.8 from 48.7 in Jan and was weaker than market expectations for a +0.3 point increase to 49.0.
The Eurozone Jan PPI of +0.6% m/m and +1.9% y/y was closed to expectations and the year-on-year figure of +1.9% was down from +2.1% in Dec.
Italy's 10-year bond yield is up by 4 bp at 4.83% today as Italy's political parties struggle to form a government. Italy's Democratic Party leader Bersani is seeking to form a narrow government targeted on a limited number of legislative initiatives. However, ex-comic Grillo's party continues to say that it will not join any government with the established parties such as those of Bersani, Berlusconi, or Monti. A second election will need to be held if a ruling coalition cannot be found.

U.S. STOCK PREVIEW
The markets this week will focus mainly on the U.S. fiscal situation after last Friday’s sequester went into effect, a heavy schedule of overseas central bank meetings, and Friday U.S. payroll report (expected +160,000). There are only 5 of the Russell 1000 companies that report earnings today: Tech Data (consensus $1.76), Golar LNG (1.67), Stratasys (0.38), Ascena Retail (0.23), MFA Financial (0.20).

March E-mini S&Ps (ESH13 -0.10%) this morning are down -5.25 points (-0.35%) on weak European and Asian stocks and the decline in China's non-manufacturing PMI report. The S&P 500 index on Friday closed higher as concerns about federal spending cuts from sequestration were offset by (1) the stronger-than-expected Feb ISM manufacturing index which unexpectedly expanded to its best level in 20-months (+1.1 to 54.2), and (2) the +1.3 point increase to 77.6 in the Feb University of Michigan consumer confidence index. Other negatives included (1) carry-over weakness from a fall in European stocks after the Eurozone Jan unemployment rate unexpectedly rose +0.1 to a record high of 11.9%, and (2) the China Feb PMI manufacturing index which unexpectedly fell -0.3 to 50.1. Closes: S&P 500 +0.23%, Dow Jones +0.25%, Nasdaq +0.33%.

OVERNIGHT U.S. STOCK MOVERS
  • Hecla Mining (HL unch) offerred to buy Aurizon Mines (AZK) for CD$4.75 per share or CD$796 million.
  • Stratasys (SSYS +1.82%) reported Q4 adjusted EPS of 40 cents, above the consensus of 38 cents.
  • HSBC (HBC -1.10%) reported FY12 EPS of 74 cents, down 20% y/y.
  • Carl Icahn reported a 13.6% stake in Herbalife (HLF -0.47%).
  • Cubic Corporation (CUB +0.79%) announced that it has received three prime contracts from the Naval Air Warfare Center Training Systems Division worth up to $298.5 million to develop courseware in support of the Littoral Combat Ship Train.
  • Transocean (RIG -0.29%) reported Q4 adjusted EPS of 91 cents, better than consensus of 82 cents.
  • Myers Industries (MYE +0.34%) raised its quarterly dividend to 9 cents from 8 cents per share.
  • Praxair (PX +0.41%) announced that it expects the impact of the Venezuelan government's devaluation of the bolivar from 4.30 to 6.30 to result in an estimated charge to net income of approximately 8 cents per diluted share in Q1 due primarily to the remeasurement of the local Venezuelan balance sheet to reflect the new official 6.30 exchange rate.
  • PDL BioPharma (PDLI -2.66%) reported Q4 EPS of 34 cents, better than consensus of 32 cents.
  • Vanguard Natural (VNR -0.14%) reported Q4 adjusted EPS of 27 cents, weaker than consensus of 34 cents.
  • Eastern Insurance Holdings (EIHI -0.16%) increased its quarterly cash dividend to 9 cents per share from 7 cents per share.

MARKET COMMENTS
June 10-year T-notes (ZNM13 +0.01%) this morning are up 3.5 ticks on some increased safe-haven demand with the sell-off in most global stock markets today. June 10-year T-note prices on Friday climbed to a 2-month high and closed higher after Jan personal income fell more-than-expected by the most in 20-years (-3.6%), along with concern the automatic spending cuts that began with Friday's sequestration will slow growth in the U.S. economy. T-note prices fell back from their best levels after U.S. Feb consumer confidence and ISM manufacturing activity unexpectedly strengthened. Closes: TYM3 +7.5, FVM3 +3.0.
The dollar index (DXY00 +0.04%) this morning is slightly higher by +0.06 (+0.07%). EUR/USD (^EURUSD) is down -0.0021 (-0.16%) and USD/JPY (^USDJPY) is down -0.08 (-0.09%). The dollar index on Friday soared to a 6-1/4 month high and closed higher as the beginning of the U.S. sequestration fueled safe-haven demand into the dollar. EUR/USD slumped to a 2-1/2 month low when the Eurozone Jan unemployment rate unexpectedly rose to a record high of 11.9%. Closes: Dollar index +0.36 (+0.44%), EUR/USD -0.00386 (-0.30%), USD/JPY +1.028 (+1.11%).
April WTI crude oil (CLJ13 +0.09%) this morning is down -0.16 (-0.18%) and April gasoline (RBJ13 +0.01%) is down -0.0087 (-0.28%). Crude oil and gasoline on Friday closed mixed. April crude posted a 2-month low after Chinese Feb manufacturing data expanded less than forecast, the dollar index surged to a 6-1/4 month high, and the U.S. sequestration began. April gasoline recovered from a 1-month low and closed higher, however, after the Feb ISM manufacturing index and Feb consumer confidence unexpectedly strengthened, which may boost fuel demand. Closes: CLJ3 -1.37 (-1.49%), RBJ3 +0.0169 (+0.54%).

GLOBAL EVENT CALENDAR03/04/2013
US0800 ETFed Vice Chairman Janet Yellen speaks at the 2013 NABE conference on ?A View from the Fed.?
0945 ETFeb New York ISM , Jan 56.7.
1100 ETUSDA weekly grain export inspections.
1145 ETFormer Fed Chairman Paul Volcker speaks at the 2013 NABE conference on ?Lessons from the Financial Collapse-Learned or Forgotten??
EUR0430 ETEurozone Mar Sentix investor confidence expected -4.3, Feb -3.9.
0500 ETEurozone Jan PPI expected +0.5% m/m and +1.9% y/y, Dec -0.2% m/m and +2.2% y/y.
UK0430 ETUK Feb construction PMI expected +0.3 to 49.0, Jan 48.7.
1901 ETUK Feb BRC sales like-for-like expected +1.0%, Jan +1.9% y/y.
JPN2030 ETJapan Jan labor cash earnings, Dec -1.7% y/y.
CHI2045 ETChina Feb HSBC services PMI, Jan 54.0.

U.S. STOCK CALENDAR03/04/2013
Company NameSymbolTimeEvent DescriptionPeriodEPS Est (US$)
Tech Data CorpTECD USBef-mktQ4 2013 Earnings ReleaseQ4 20131.76
Golar LNG LtdGOL NOBef-mktY 2012 Earnings ReleaseY 20121.667
Stratasys LtdSSYS USBef-mktQ4 2012 Earnings ReleaseQ4 20120.383
Stratasys LtdSSYS US8:30Q4 2012 Earnings CallQ4 2012
Tech Data CorpTECD US9:00Q4 2013 Earnings CallQ4 2013
Golar LNG LtdGOL NO9:30Y 2012 Earnings CallY 2012
Dominion Resources Inc/VAD US10:00Analyst MeetingY 2013
Ascena Retail Group IncASNA US16:00Q2 2013 Earnings ReleaseQ2 20130.228
Ascena Retail Group IncASNA US16:30Q2 2013 Earnings CallQ2 2013
Cisco Systems IncCSCO USVirnetX vs. Cisco Patent-Infringement Trial Begins
AutoNation IncAN USFebruary 2013 Sales and Revenue Release2013

Wednesday, April 27, 2011

5 stocks under $10 on the move

This morning I used Barchart to screen for stocks trading under $10 that are hitting the most frequent new highs and came up with 5 stocks you might want to put on your watch lists.

Goldfield (GV) -- is a leading provider of electrical construction and maintenance services in the energy infrastructure industry in the southeastern United States. The company specializes in installing and maintaining electrical transmission lines for a wide range of electric utilities. Goldfield is also involved in the development of high-end condominium projects on Florida's east coast.


Technical Factors:
  • 96% Barchart technical buy signal
  • Trend Spotter buy signal
  • 21 new highs and up 27.27% in the last month
  • Relative Strength Index
  • Trades at .42 with a 50 day moving average of .36
There are no Wall Street brokerage analysts following this stock

On Motley Fool there is only one member giving an opinion but it is a buy

PDL BioPharma (PDLI) -- Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.


Technical Factors:
  • 96% Barchart technical buy signal
  • Trend Spotter buy signal
  • 14 new highs and up 14.65% in the last month
  • Relative Strength Index 67.12% and rising
  • Trades around 6.36 with a 50 day moving average of 5.68
Fundamental Factors:
  • Wall Street brokerage analysts published 3 buy and 4 hold recommendations
  • Sales projected to increase by 12.50% this year and 9.10% next year
  • Earnings are estimated to increase by 31.50% this year,19.70% next year and 26.00% annually for the next 5 years 
General Investor Sentiment:
  • 1,213 investors following this stock on Motley Fool
  • CAPS members 860 to 42 that the stock will beat the market
  • The more experienced All Stars agree 299 to 12
NOTE:  Since Jim Cramer advised a sell on this stock on 3/8/2011 the stock surged up 11.62%

Guaranty Bancorp (GBNK) -- is a bank holding company with one wholly owned bank subsidiary, Guaranty Bank and Trust Company. Guaranty Bank and Trust Company provides banking and other financial services, including real estate, construction, commercial and industrial, energy, consumer and agriculture loans, to consumers and small and medium-sized businesses, including the owners and employees of those businesses, through 36 community banking branches in the Colorado Front Range. Guaranty Bank also provides trust services, including personal trust administration, estate settlement, investment management accounts and self-directed IRAs.


Technical Factors:
  • 100% Barchart short term technical buy signals
  • Trend Spotter buy signal
  • 13 new highs and up 10.85% in the last month
  • Relative Strength Index 42.11% and rising
  • Trades around 1.43 with a 50 day moving average of 1.29
Fundamental Factors:
  • Only 1 Wall Street brokerage is following this stock and he has a hold recommendation released
  • Sales are expected to increase by 26.70% next year
  • Earnings are expected to increase by 73.80% this year and increase annually by 10.70% for the next 5 years
General Investor Sentiment:
  • The 46 investors following this stock on Motley Fool are very split on its future
  • CAPS members are evenly split 18 to 18 that the stock will continue to beat the market
  • The experienced All Stars are negative by a 3 to 7 vote
Medallion Financial (TAXI) -- is a specialty finance company that originates and services loans that finance taxicab medallions and various types of commercial loans.


Technical Factors: 
  • 100% Barchart technical buy signal
  • Trend Spotter buy signal
  • 13 new highs and up 5.74% in the last month
  • Relative strength Index 63.60% and rising
  • Trades around 8.89 with a 50 day moving average of 8.39
Fundamental Factors:
  • Only 1 Wall Street brokerage analysts following this issue and he has a hold
  • Sales are projected to be just slightly negative this year
  • Earnings are another thing with a growth of 51.00% projected for this year, 6.20% for next year and 10.00% annually for the next 5 years
Vonage (VG) -- is a leading provider of digital phone services with over two million subscriber lines. Their award-winning technology enables anyone to make and receive phone calls with a touch tone telephone almost anywhere a broadband Internet connection is available. They offer feature-rich and cost-effective communication services that offer users an experience similar to traditional telephone services.The Residential Premium Unlimited and Small Business Unlimited calling plans offer consumers unlimited local and long distance calling, and popular features like call waiting, call forwarding and voicemail - for one low, flat monthly rate. Vonage's service is sold on the web and through national retailers including Best Buy, Circuit City, Wal-Mart Stores Inc. and Target and is available to customers in the U.S., Canada and the United Kingdom.


Technical Factors:
  • 96% Barchart technical buy signal
  • Trend Spotter buy signal
  • 13 new highs and up 26.35% in the last month
  • Relative Strength Index 68.388% and rising
  • Trades around 5.21 with a 50 day moving average of 4.45
Fundamental Factors:
  • Wall Street brokerage analysts have 1 strong buy, 1 buy and 1 hold recommendations released
  • Sales are expected to increase by 1.00% this year and 2.00% next year
  • Earnings are estimated to increase by 285.70% this year, 3.80% next year and 2.50% annually for the next 5 years
General Investor Sentiment:
  • Over 1900 investors on Motley Fool have expressed opinions on this stocks
  • CPAS members vote 475 to 1,105 taht the stock will NOT beat the market
  • The more experienced All Stars are also negative 83 to 330
Jim Van Meerten is an analyst for  Marketocracy Capital Management.  He shares his knowledge and experience from over 40 years of investing in stocks, mutual funds and ETFs on  Barchart.com  in his daily blog -- Barchart Portfolio Blogs.







Tuesday, January 18, 2011

PDL Biopharma -- PDLI -- deleted

This morning I deleted PDL Biopharma (PDLI)  from the Barchart Van Meerten Speculative portfolio for negative price trends:

  • 40% Barchart technical sell signal
  • Trend Spotter (tm) sell signal
  • Trading below its 20, 50 and 100 day moving averages
  • Lost 18.02% from its most recent high
  • Relative Strength Index 30.40% and falling
Jim Van Meerten is a professional investor with over 40 year experience in investing in stocks, mutual funds and ETFs.  He shares his knowledge on Barchart in his daily blogs -- Barchart Portfolio Blogs.

Monday, December 20, 2010

PDL Biopharma -- PDLI -- added

I added PDL Biopharma (PDLI) to the Barchart Van Meerten Specualtive portfolio --Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.

Recent price momentum has given the stock a 100% Barchart technical buy signal -- With 16 new highs and an 11.80% price appreciation in the last 20 sessions the stock looks great.  The Relative Strength Index is 74.94% and rising.  The stock trades around 6.31 which is above its 50 day moving average of 5.66.

Wall Street analysts look for sales to increase by 12.50% next year with earnings per share increasing by 37.40% for the same period.  The 5 year projected  EPS annual growth rate of 26.00% has resulted in 2 buy and 5 hold recommendations for their clients.

The Fools on Motley Fool have the CAPS members voting 807 to 34 that the stock will beat the market with the more experienced All Stars voting 301 to 9.  Fool notes that the last 6 articles in Wall Street periodicals have all been positive.

The stock was added because:

  • 100% Barchart technical buy signal
  • 16 new highs and up 11.80% in the last month
  • Wall Street brokerages\project double digit increases in sales and earnings
  • Positive investor sentiment

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.